Lotus Bio-Technology Development Corp.
LBTD · OTC
12/31/2017 | 9/30/2017 | 6/30/2017 | 3/31/2017 | |
|---|---|---|---|---|
| Market Cap | $7 | $2 | $10 | $12 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $7 | $2 | $10 | $12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0 | -0 | -0.009 |
| % Growth | 98.1% | -9,097.1% | 100% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |